Vitura Health Limited (ASX:VIT) is set to present its 2024 full-year financial results in an investor webinar scheduled for Wednesday, 4 September 2024 at 10.00 am (Melbourne time). The company, a leading digital health platform business, will use the webinar to showcase its FY24 highlights and provide insights into its strategic outlook. The presentation will cover the company's diversified operations, financial performance, and future growth initiatives.
Vitura's future focus is on innovating the delivery of healthcare by building a centralised healthcare experience that connects and enhances each stage of the patient experience and journey throughout their lifetime. The company's FY24 highlights include the acquisition of Doctors on Demand, expansion into new product and service verticals, and a strategy reset to respond to changing market dynamics. Despite a challenging environment, Vitura achieved a 5.6% revenue growth in FY24, driven by the positive impact of new products and clinical verticals. The company is committed to maintaining market leadership in medicinal cannabis and nicotine vaping products while enhancing its technology and expanding its customer and market base. The new leadership team is focused on execution and driving sustainable growth.
Vitura Health Limited (ASX:VIT) reported a 5.6% increase in group operating revenue in FY24, supported by the acquisition of Doctors on Demand. The company faced challenges in the medicinal cannabis market due to increased competition, leading to a reduction in average gross margin on products. However, Vitura's strategy reset and focus on new product and service verticals are expected to drive revenue growth in FY25. The company aims to improve EBITDA margin and OPEX efficiency while expanding its customer base and enhancing its technology. With a strong leadership team and a unique digital health ecosystem, Vitura remains focused on delivering improved financial metrics and sustaining its growth trajectory.